The role of dihydrosphingolipids in disease
Dihydrosphingolipids refer to sphingolipids early in the biosynthetic pathway that do not contain a C4-trans-double bond in the sphingoid backbone: 3-ketosphinganine (3-ketoSph), dihydrosphingosine (dhSph), dihydrosphingosine-1-phosphate (dhS1P) and dihydroceramide (dhCer). Recent advances in resear...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Birkhauser Verlag
2018
|
| Online Access: | http://hdl.handle.net/20.500.11937/74867 |
Similar Items
Exogenous dihydrosphingosine 1 phosphate mediates collagen synthesis in cardiac fibroblasts through JAK/STAT signalling and regulation of TIMP1
by: Magaye, R.R., et al.
Published: (2020)
by: Magaye, R.R., et al.
Published: (2020)
Angiotensin receptor neprilysin inhibitor LCZ696: Pharmacology, pharmacokinetics and clinical development
by: Hua, Y., et al.
Published: (2017)
by: Hua, Y., et al.
Published: (2017)
Cardiac fibrosis in the ageing heart: Contributors and mechanisms
by: Lu, L., et al.
Published: (2017)
by: Lu, L., et al.
Published: (2017)
Prescription of physical activity in the management of high blood pressure in Australian general practices
by: Smith, B., et al.
Published: (2019)
by: Smith, B., et al.
Published: (2019)
The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis
by: Brady, S., et al.
Published: (2009)
by: Brady, S., et al.
Published: (2009)
Outcomes and excess costs among patients with cardiovascular disease
by: Ademi, Z., et al.
Published: (2013)
by: Ademi, Z., et al.
Published: (2013)
Economic implications of obesity among people with atherothrombotic disease
by: Ademi, Z., et al.
Published: (2010)
by: Ademi, Z., et al.
Published: (2010)
Risk of Progression of Nonalbuminuric Diabetic Kidney Disease to End-Stage Renal Disease: The CRIC Study
by: Koye, D., et al.
Published: (2017)
by: Koye, D., et al.
Published: (2017)
COST-EFFECTIVENESS OF RENAL DENERVATION THERAPY FOR TREATMENT RESISTANT HYPERTENSION: A BEST CASE SCENARIO
by: Chowdhury, E., et al.
Published: (2018)
by: Chowdhury, E., et al.
Published: (2018)
Cost-effectiveness of renal denervation therapy for treatment-resistant hypertension: A best case scenario
by: Chowdhury, E., et al.
Published: (2018)
by: Chowdhury, E., et al.
Published: (2018)
Androgens And Cardiovascular Disease In Men
by: Yeap, B., et al.
Published: (2019)
by: Yeap, B., et al.
Published: (2019)
The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: Best case scenario analysis using a Markov model
by: Zomer, E., et al.
Published: (2012)
by: Zomer, E., et al.
Published: (2012)
Epidemiology of cardiovascular disease
by: Reid, Christopher, et al.
Published: (2016)
by: Reid, Christopher, et al.
Published: (2016)
Prevention of Cardiovascular Disease
by: Owen, A., et al.
Published: (2012)
by: Owen, A., et al.
Published: (2012)
Predicting the effectiveness of prevention: A role for epidemiological modeling
by: Walls, H., et al.
Published: (2008)
by: Walls, H., et al.
Published: (2008)
Stable Chronic Obstructive Pulmonary Disease
by: Reid, D., et al.
Published: (2014)
by: Reid, D., et al.
Published: (2014)
Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data
by: Ademi, Z., et al.
Published: (2014)
by: Ademi, Z., et al.
Published: (2014)
Drug treatment and cost of cardiovascular disease in Australia
by: Ademi, Z., et al.
Published: (2009)
by: Ademi, Z., et al.
Published: (2009)
Cardiovascular disease in Australia: Calm before a new storm?
by: Reid, Christopher
Published: (2013)
by: Reid, Christopher
Published: (2013)
Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012)
by: Zomer, E., et al.
Published: (2012)
Myxomatous mitral valve disease in a Shih Tzu dog
by: Teoh, Y. B., et al.
Published: (2017)
by: Teoh, Y. B., et al.
Published: (2017)
Risk factor management in a contemporary Australian population at increased cardiovascular disease risk
by: Campbell, D., et al.
Published: (2018)
by: Campbell, D., et al.
Published: (2018)
The Role of Clinical Registries in Monitoring Drug Safety and Efficacy
by: Reid, Christopher
Published: (2015)
by: Reid, Christopher
Published: (2015)
Incidence of chronic kidney disease among people with diabetes: A systematic review of observational studies
by: Koye, D., et al.
Published: (2017)
by: Koye, D., et al.
Published: (2017)
Translational research for chronic respiratory disease: intercepting the bile aspiration paradigm
by: Reen, F., et al.
Published: (2014)
by: Reen, F., et al.
Published: (2014)
Intercepting the Bile Aspiration Paradigm: Innovative Intervention for Chronic Respiratory Disease
by: Reen, F., et al.
Published: (2015)
by: Reen, F., et al.
Published: (2015)
PROLONGED EFFECTIVENESS OF CORONARY ARTERY BYPASS SURGERY VERSUS DRUG-ELUTING STENTS IN DIABETICS WITH MULTI-VESSEL DISEASE: AN UPDATED META-ANALYSIS
by: Ariyaratne, T., et al.
Published: (2012)
by: Ariyaratne, T., et al.
Published: (2012)
Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: An updated systematic review and meta-analysis
by: Ariyaratne, T., et al.
Published: (2014)
by: Ariyaratne, T., et al.
Published: (2014)
Is It Cost-Effective To Increase Aspirin Use in Outpatient Settings for Primary or Secondary Prevention? Simulation Data from the REACH Registry Australian Cohort
by: Ademi, Z., et al.
Published: (2013)
by: Ademi, Z., et al.
Published: (2013)
Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)
by: Zomer, E., et al.
Published: (2018)
Population screening an important step in identifying and increasing awareness of cardiovascular disease in developing countries
by: Davidson, P., et al.
Published: (2012)
by: Davidson, P., et al.
Published: (2012)
Cardio classics revisited: Focus on the role of amlodipine
by: Owen, A., et al.
Published: (2012)
by: Owen, A., et al.
Published: (2012)
The effect of taking blood pressure lowering medication at night on cardiovascular disease risk. A systematic review
by: Ho, Chau L.B., et al.
Published: (2021)
by: Ho, Chau L.B., et al.
Published: (2021)
The Role of Luteinizing Hormone in Alzheimer’s Disease
by: Barron, A., et al.
Published: (2010)
by: Barron, A., et al.
Published: (2010)
Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization
by: Elbez, Y., et al.
Published: (2016)
by: Elbez, Y., et al.
Published: (2016)
Rationalising the role of Keratin 9 as a biomarker for Alzheimer’s disease
by: Richens, Joanna L., et al.
Published: (2016)
by: Richens, Joanna L., et al.
Published: (2016)
A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era
by: Ariyaratne, T., et al.
Published: (2016)
by: Ariyaratne, T., et al.
Published: (2016)
Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: A systematic review and meta-analysis
by: Ho, C.L.B., et al.
Published: (2021)
by: Ho, C.L.B., et al.
Published: (2021)
Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: a systematic review of data from preclinical studies
by: Chin, K., et al.
Published: (2019)
by: Chin, K., et al.
Published: (2019)
B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease
by: Kotecha, D., et al.
Published: (2019)
by: Kotecha, D., et al.
Published: (2019)